Great Lakes Advisors’s Editas Medicine EDIT Stock Holding History

Great Lakes Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-380,011	Closed	-$26.6M	–	707
2020 Q4	$26.6M	Buy	+380,011	New	+$15.6M	0.48%	56
2019 Q2	–	Sell	-276,195	Closed	-$6.75M	–	540
2019 Q1	$6.75M	Buy	+276,195	New	+$6.25M	0.15%	156
2017 Q4	–	Sell	-10,764	Closed	-$258K	–	583
2017 Q3	$258K	Buy	+10,764	New	+$205K	0.01%	545

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Great Lakes Advisors's EDIT Position: Q1 2021 in Review

Great Lakes Advisors sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 380,011 shares — an estimated $26.6M sold.

Great Lakes Advisors first reported a position in EDIT in Q3 2017 and held it in 3 quarters. The position peaked at $26.6M in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

Great Lakes Advisors reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
Great Lakes Advisors sold 380,011 Editas Medicine shares in Q1 2021, an estimated $26.6M.
Great Lakes Advisors first reported a position in Editas Medicine in Q3 2017 and held it in 3 quarters.
Great Lakes Advisors's Editas Medicine position peaked at $26.6M in Q4 2020.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Great Lakes Advisors's 13F filing for Q1 2021, filed 3 May 2021.